Suppr超能文献

采用液相色谱-串联质谱法检测药品和专利中药中的 28 种皮质类固醇。

Detection of 28 Corticosteroids in Pharmaceutical and Proprietary Chinese Medicinal Products Using Liquid Chromatography-Tandem Mass Spectrometry.

机构信息

Hospital Authority Toxicology Reference Laboratory, Room 1414, Block G, 2-10 Princess Margaret Hospital Road, Lai Chi Kok, Kowloon, Hong Kong.

出版信息

J Chromatogr Sci. 2021 May 20;59(6):548-554. doi: 10.1093/chromsci/bmaa140.

Abstract

With their potent anti-inflammatory effects, corticosteroids are popular adulterants in illicit health products for allergies, dermatitis and pain control. Their illegal supply over the counter is also a common practice for similar conditions. Prolonged, unsupervised usage of corticosteroids often leads to severe adverse effects including Cushing syndrome, adrenal insufficiency and immunosuppression. Confirming clinical suspicion of unsupervised corticosteroid usage is challenging. Apart from evaluating the adrenal function, identifying the concerned drug is the most direct proof of its consumption. While detecting corticosteroids or their metabolites in biological specimens is convincing evidence of their usage, such approach is analytically difficult. More importantly, this approach would not be useful if the patient has stopped taking the drug for some time-a situation that is often encountered clinically. We advocate a more direct approach by measuring corticosteroids in suspicious medicinal products. In the current study, a liquid chromatography-tandem mass spectrometry method for simultaneous detection of 28 corticosteroids in pharmaceutical and proprietary Chinese medicine products was developed and validated for the purpose. The method was applied to 388 cases of suspected unsupervised corticosteroids usage. Among 1,000 products tested, corticosteroids were found in 276 of them and confirmed the clinical suspicion.

摘要

由于具有强大的抗炎作用,皮质类固醇类药物成为治疗过敏、皮炎和疼痛控制等非法保健产品中常见的掺杂物。同样地,未经监管的皮质类固醇类药物的非法供应也很常见。对于类似情况,皮质类固醇类药物的长期、未经监管的使用常常会导致严重的不良反应,包括库欣综合征、肾上腺皮质功能不全和免疫抑制。确认未经监管使用皮质类固醇类药物的临床怀疑具有挑战性。除了评估肾上腺功能外,识别相关药物是其使用的最直接证据。虽然在生物样本中检测皮质类固醇类药物或其代谢物是其使用的有力证据,但这种方法在分析上具有难度。更重要的是,如果患者已经停止使用药物一段时间,这种方法通常在临床上会遇到,那么这种方法就没有用了。我们提倡通过测量可疑药物中的皮质类固醇类药物来采取更直接的方法。在目前的研究中,开发并验证了一种同时检测药物和专利中药产品中 28 种皮质类固醇类药物的液相色谱-串联质谱法。该方法应用于 388 例疑似未经监管使用皮质类固醇类药物的案例中。在所测试的 1000 种产品中,有 276 种产品中发现了皮质类固醇类药物,证实了临床怀疑。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验